During the past few years, a number of trends in laboratory medicine have affected the development and implementation of automation in lab analyzers. Such trends are related to reducing costs, running tests with fewer lab personnel, and maintaining quick turnaround times for test results. IVD manufacturers have been responding to such trends in automation and instrumentation in different ways.
One trend is automating the preanalytical sample-preparation...
With every article published and conference presentation given on middleware, the growing perception has been that it is synonymous with autoverification and nothing more. However, while middleware can help with the mundane and error-prone task of results verification, what also must be realized is that it can offer so much more. Otherwise, those labs that have it and those that seek it are not exploiting the full potential and real value of...
The dwindling number of clinical microbiologists is one fact that the IVD industry cannot ignore. A recent study found that between 1983 and 1999, enrollment in medical technology training programs declined 38% in the United States, and during that same period, 57% of medical technology schools closed their doors. But even though about 40% of today's laboratory professionals will be eligible to retire between 2005 and 2010, the introduction of more...
During the past few years, a number of trends in laboratory medicine have affected the development and implementation of automation in lab analyzers. Such trends are related to reducing costs, running tests with fewer lab personnel, and maintaining quick turnaround times for test results. This special supplement on automation and instrumentation for IVDs explores such trends and how manufacturers have responded to them.
One trend is...
Figure 1. Clinical laboratories are being advised that automation is the
key to survival.
Responding appropriately to economic pressures is key to running a successful laboratory today. Market forces are creating a climate of intense competition that affects IVD laboratories, which are being advised that automation is the key to survival.
Laboratories should be cognizant of the fact that they exist in a business-oriented world and...
Editor's note: The following is an update of an article that was originally published in the July/August 2005 issue of IVD Technology.
Figure 1. The Tigris system by Gen-Probe Inc. (San Diego).
In recent years, nucleic acid amplification tests (NAATs) for infectious diseases have come into widespread use in many clinical microbiology and blood-screening laboratories. A number of these tests have been approved by FDA and then...
Joseph Meyer is vice president of
marketing for the centralized diagnostics business unit at Roche Diagnostics
(Indianapolis). He is responsible for
setting and executing the company's U.S. marketing strategy and communicating product and market requirements.
He can be reached at joseph-f.meyer
@roche.com.
Pressure from several directions is making it increasingly imperative that...
The AutoMate 800 sample processes by Beckman Coulter Inc. (Photo courtesy Beckman Coulter Inc.)
Despite an increasing awareness of the problem, the mishandling of test samples in clinical laboratories continues to contribute to the inefficient use of resources during both the pre- and postanalytical phases of diagnostic testing. More critically, mishandling is also a common source of laboratory errors.
A recent landmark study conducted by the U.S...
Figure 1. (click to enlarge) A few of the systems that are a part of the automated testing portfolio of BD Diagnostics (Franklin Lakes, NJ). Updating such a wide range of instruments to address technological developments and consumer expectations poses challenges.
Clinical microbiology departments face multiple challenges due to the complexity of today's changing microorganisms. These challenges are made more complex due to ongoing staffing and...
The Verigene system by Nanosphere Inc. (Northbrook, IL) is a nanotechnology-based molecular diagnostic system for nucleic acids and proteins.
In recent years, the number of clinically relevant singlenucleotide polymorphisms (SNPs), in combination with linkage disequilibrium information, has increased exponentially.1 Consequently, molecular analysis of allelic variations has been gaining momentum in diagnostics. Among the genes that contain...